These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 32658131)

  • 21. Retention, engagement, and adherence to pre-exposure prophylaxis for men who have sex with men and transgender women in PrEP Brasil: 48 week results of a demonstration study.
    Grinsztejn B; Hoagland B; Moreira RI; Kallas EG; Madruga JV; Goulart S; Leite IC; Freitas L; Martins LMS; Torres TS; Vasconcelos R; De Boni RB; Anderson PL; Liu A; Luz PM; Veloso VG;
    Lancet HIV; 2018 Mar; 5(3):e136-e145. PubMed ID: 29467098
    [TBL] [Abstract][Full Text] [Related]  

  • 22. On-demand pre-exposure prophylaxis with tenofovir disoproxil fumarate plus emtricitabine among men who have sex with men with less frequent sexual intercourse: a post-hoc analysis of the ANRS IPERGAY trial.
    Antoni G; Tremblay C; Delaugerre C; Charreau I; Cua E; Rojas Castro D; Raffi F; Chas J; Huleux T; Spire B; Capitant C; Cotte L; Meyer L; Molina JM;
    Lancet HIV; 2020 Feb; 7(2):e113-e120. PubMed ID: 31784343
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Protocol for a multicenter, real-world study of HIV pre-exposure prophylaxis among men who have sex with men in China (CROPrEP).
    Wang H; Zhang Y; Mei Z; Jia Y; Leuba SI; Zhang J; Chu Z; Ding H; Jiang Y; Geng W; Shang H; Xu J
    BMC Infect Dis; 2019 Aug; 19(1):721. PubMed ID: 31416439
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Risk factors for HIV infection among men who have sex with men in the ANRS IPERGAY PrEP trial.
    Gras J; Pillet M; Antoni G; Cua E; Charreau I; Raffi F; Chidiac C; Chas J; Tremblay C; Spire B; Delaugerre C; Meyer L; Molina JM;
    Sex Transm Infect; 2022 Aug; 98(5):383-386. PubMed ID: 34663696
    [TBL] [Abstract][Full Text] [Related]  

  • 25. HIV Preexposure Prophylaxis Initiation at a Large Community Clinic: Differences Between Eligibility, Awareness, and Uptake.
    Shover CL; Javanbakht M; Shoptaw S; Bolan RK; Lee SJ; Parsons JT; Rendina J; Gorbach PM
    Am J Public Health; 2018 Oct; 108(10):1408-1417. PubMed ID: 30138062
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pre-exposure Prophylaxis Awareness Among Gay and Other Men who have Sex with Men in Vancouver, British Columbia, Canada.
    Lachowsky NJ; Lin SY; Hull MW; Cui Z; Sereda P; Jollimore J; Rich A; Montaner JS; Roth EA; Hogg RS; Moore DM
    AIDS Behav; 2016 Jul; 20(7):1408-22. PubMed ID: 26884310
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevalence and Correlates of Unhealthy Alcohol and Drug Use Among Men Who Have Sex with Men Prescribed HIV Pre-exposure Prophylaxis in Real-World Clinical Settings.
    Ogbuagu O; Marshall BDL; Tiberio P; Ogunbajo A; Barakat L; Montgomery M; Almonte A; Wray T; Williams EC; Edelman EJ; Chan PA
    AIDS Behav; 2019 Jan; 23(1):190-200. PubMed ID: 30145707
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Club drug users had higher odds of reporting a bacterial STI compared with non-club drug users: results from a cross-sectional analysis of gay and bisexual men on HIV pre-exposure prophylaxis.
    John SA; Parsons JT; Rendina HJ; Grov C
    Sex Transm Infect; 2019 Dec; 95(8):626-628. PubMed ID: 30126949
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High incidence of HCV in HIV-negative men who have sex with men using pre-exposure prophylaxis.
    Hoornenborg E; Coyer L; Boyd A; Achterbergh RCA; Schim van der Loeff MF; Bruisten S; de Vries HJC; Koopsen J; van de Laar TJW; Prins M;
    J Hepatol; 2020 May; 72(5):855-864. PubMed ID: 31862485
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Substantial Need for Preexposure Prophylaxis Among Men Who Have Sex With Men in Hanoi, Vietnam.
    Bhatia R; Le Minh G; An LT; Thai TT; Bui H; Ngoc LB; Vu D; Abdul-Quader A
    Sex Transm Dis; 2021 May; 48(5):e56-e58. PubMed ID: 32890336
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interest in HIV pre-exposure prophylaxis in men who have sex with men in West Africa (CohMSM ANRS 12324 - Expertise France).
    Coulaud PJ; Sagaon-Teyssier L; M'madi Mrenda B; Maradan G; Mora M; Bourrelly M; Dembélé Keita B; Keita AA; Anoma C; Babo Yoro SA; Dah TTE; Coulibaly C; Mensah E; Agbomadji S; Bernier A; Couderc C; Laurent C; Spire B;
    Trop Med Int Health; 2018 Oct; 23(10):1084-1091. PubMed ID: 30055043
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A Latent Class Analysis of Risk Factors for Acquiring HIV Among Men Who Have Sex with Men: Implications for Implementing Pre-Exposure Prophylaxis Programs.
    Chan PA; Rose J; Maher J; Benben S; Pfeiffer K; Almonte A; Poceta J; Oldenburg CE; Parker S; Marshall BD; Lally M; Mayer K; Mena L; Patel R; Nunn AS
    AIDS Patient Care STDS; 2015 Nov; 29(11):597-605. PubMed ID: 26389735
    [TBL] [Abstract][Full Text] [Related]  

  • 33. HIV Pre-exposure Prophylaxis (PrEP) Uptake Among Gay and Bisexual Men in Australia and Factors Associated With the Nonuse of PrEP Among Eligible Men: Results From a Prospective Cohort Study.
    Hammoud MA; Vaccher S; Jin F; Bourne A; Maher L; Holt M; Bavinton BR; Haire B; Degenhardt L; Grulich A; Prestage GP
    J Acquir Immune Defic Syndr; 2019 Jul; 81(3):e73-e84. PubMed ID: 30973548
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Brief Report: Changes in Behavior After PrEP Initiation Among Australian Gay and Bisexual Men.
    Prestage G; Maher L; Grulich A; Bourne A; Hammoud M; Vaccher S; Bavinton B; Holt M; Jin F
    J Acquir Immune Defic Syndr; 2019 May; 81(1):52-56. PubMed ID: 30768489
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An analysis of baseline data from the PROUD study: an open-label randomised trial of pre-exposure prophylaxis.
    Dolling DI; Desai M; McOwan A; Gilson R; Clarke A; Fisher M; Schembri G; Sullivan AK; Mackie N; Reeves I; Portman M; Saunders J; Fox J; Bayley J; Brady M; Bowman C; Lacey CJ; Taylor S; White D; Antonucci S; Gafos M; McCormack S; Gill ON; Dunn DT; Nardone A;
    Trials; 2016 Mar; 17():163. PubMed ID: 27013513
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Can the combination of TasP and PrEP eliminate HIV among MSM in British Columbia, Canada?
    Lima VD; Zhu J; Card KG; Lachowsky NJ; Chowell-Puente G; Wu Z; Montaner JSG
    Epidemics; 2021 Jun; 35():100461. PubMed ID: 33984688
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Use of electronic health record data and machine learning to identify candidates for HIV pre-exposure prophylaxis: a modelling study.
    Marcus JL; Hurley LB; Krakower DS; Alexeeff S; Silverberg MJ; Volk JE
    Lancet HIV; 2019 Oct; 6(10):e688-e695. PubMed ID: 31285183
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gonorrhoea and chlamydia diagnosis as an entry point for HIV pre-exposure prophylaxis: a modelling study.
    Kasaie P; Schumacher CM; Jennings JM; Berry SA; Tuddenham SA; Shah MS; Rosenberg ES; Hoover KW; Gift TL; Chesson H; German D; Dowdy DW
    BMJ Open; 2019 Mar; 9(3):e023453. PubMed ID: 30837248
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Preparing for PrEP: estimating the size of the population eligible for HIV pre-exposure prophylaxis among men who have sex with men in England.
    Mitchell HD; Desai S; Mohammed H; Ong KJ; Furegato M; Hall V; Desai M; Saunders JM; Hughes G; Field N; Gill ON
    Sex Transm Infect; 2019 Nov; 95(7):484-487. PubMed ID: 31010953
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Predictors of interest in taking pre-exposure prophylaxis among men who have sex with men who used a rapid HIV-testing site in Montreal (Actuel sur Rue).
    Lebouché B; Engler K; Machouf N; Lessard D; Thomas R
    HIV Med; 2016 Feb; 17(2):152-8. PubMed ID: 26177691
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.